- Home
- News
- Topics
- FDA Week
- Inside CMS
- Inside Drug Pricing
- Health Exchange Alert
- Inside TeleHealth
- About Us
Gain-of-function research, which is used to better understand which pathogens have the potential to become a pandemic, should be subject to additional government oversight since it could accidentally or deliberately be misused, experts from academia and the biopharmaceutical industry told members of the Senate Homeland Security committee’s emerging threats subcommittee Wednesday (Aug. 3).
Advertisement
Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.
Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.
© 2002-2025. Inside Washington Publishers | Contact Us